Technical Analysis for BCTX - BriaCell Therapeutics Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
New 52 Week Closing Low | Bearish | 0.00% | |
New Downtrend | Bearish | 0.00% | |
Expansion Breakdown | Bearish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% |
Alert | Time |
---|---|
Down 2 ATRs | about 16 hours ago |
60 Minute Opening Range Breakdown | about 19 hours ago |
2x Volume Pace | about 20 hours ago |
1.5x Volume Pace | about 20 hours ago |
3x Volume Pace | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/10/2024
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.59 |
52 Week Low | 1.6075 |
Average Volume | 74,888 |
200-Day Moving Average | 4.43 |
50-Day Moving Average | 2.50 |
20-Day Moving Average | 2.17 |
10-Day Moving Average | 2.17 |
Average True Range | 0.20 |
RSI (14) | 25.37 |
ADX | 25.15 |
+DI | 13.09 |
-DI | 36.39 |
Chandelier Exit (Long, 3 ATRs) | 1.85 |
Chandelier Exit (Short, 3 ATRs) | 2.20 |
Upper Bollinger Bands | 2.45 |
Lower Bollinger Band | 1.89 |
Percent B (%b) | -0.46 |
BandWidth | 25.97 |
MACD Line | -0.15 |
MACD Signal Line | -0.13 |
MACD Histogram | -0.0109 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.30 | ||||
Resistance 3 (R3) | 2.36 | 2.21 | 2.19 | ||
Resistance 2 (R2) | 2.21 | 2.04 | 2.17 | 2.15 | |
Resistance 1 (R1) | 1.92 | 1.93 | 1.84 | 1.85 | 2.11 |
Pivot Point | 1.76 | 1.76 | 1.72 | 1.73 | 1.76 |
Support 1 (S1) | 1.47 | 1.59 | 1.40 | 1.41 | 1.15 |
Support 2 (S2) | 1.32 | 1.49 | 1.29 | 1.11 | |
Support 3 (S3) | 1.03 | 1.32 | 1.07 | ||
Support 4 (S4) | 0.96 |